Gut Microbiome Is Associated With the Response to Chemoradiotherapy in Patients With Non-small Cell Lung Cancer

被引:11
|
作者
Qiu, Bo [1 ]
Xi, Yu [2 ,3 ]
Liu, FangJie [1 ]
Li, Ying [2 ]
Xie, XinQiang [2 ]
Guo, JinYu [1 ]
Guo, SuPing [1 ]
Wu, YingJia [1 ]
Wu, Lei [2 ]
Liang, TingTing [2 ]
Ding, Yu [2 ]
Zhang, Jumei [2 ]
Wu, QingPing [2 ]
Liu, Hui [1 ]
机构
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Radiat Oncol,Canc Ctr, Guangzhou, Peoples R China
[2] Guangdong Acad Sci, Inst Microbiol, Guangdong Prov Key Lab Microbial Safety & Hlth, State Key Lab Appl Microbiol Southern China, Guangzhou, Peoples R China
[3] South China Univ Technol, Sch Biol & Biol Engn, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
PREDICTIVE FACTORS; RADIOTHERAPY; CHEMORADIATION; BACTERIA; THERAPY;
D O I
10.1016/j.ijrobp.2022.07.032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To explore the dynamic change of gut microbiota and its predictive role in progression-free survival (PFS) in nonsmall cell lung cancer (NSCLC) after concurrent chemoradiotherapy (CCRT). Methods and Materials: Forty-one patients with NSCLC in 2 phase 2 trials (NCT02573506 and NCT03006575) were analyzed. A total of 102 fecal samples were collected at 3 time points (T0, before CCRT; T1, 2 weeks after the initiation of CCRT; and T2, the end of CCRT). Gut microbiota composition and functionality were analyzed by 16S rRNA gene sequencing and shotgun metagenomics, respectively. Alpha diversity, taxonomic composition, and KEGG functional pathways were compared between patients in the long-PFS group (PFS & GE;11.0 months) and short-PFS group (PFS <11.0 months). A random forest classifier was constructed to identify microbial signature related to PFS. Clinical and microbial factors potentially predictive of PFS were assessed in the univariate and multivariate Cox regression analysis. Results: The abundance of Bacteroidota and Proteobacteria increased, while the abundance of Firmicutes decreased after CCRT. Shannon index (P = .006) and PD index (P = .022) were significantly higher in the long-PFS group than for those in the short-PFS group at T1. The PFS-prediction microbial signature at T1 included unclassified members of the Lanchospiraceae spp., such as NK4A136 and UCG-003 groups, Dorea sp., various strains from within the Eubacterium hallii and E. siraeum groups, and an unclassified member of the Muribaculaceae, which yielded an area under the ROC curve of 0.87. These discriminatory genera mostly belong to phylum Firmicutes/family Clostridia. Multivariate analysis indicated PD index (HR = 8.036, P = .016) and the abundance of Dorea sp. at T1 (HR = 4.186, P = .043) were independent predictors of PFS. The KEGG pathways at T1 overrepresented in the long-PFS group included fatty acid metabolism, fatty acid biosynthesis, and arginine biosynthesis. Those overrepresented in the short-PFS group included lipopolysaccharide biosynthesis, ascorbate and aldarate metabolism, and biosynthesis of vancomycin group antibiotics.Conclusions: Gut microbiota composition and functionality at 2 weeks after the initiation of CCRT were associated with PFS in NSCLC. Further research is needed to confirm these results. & COPY; 2022 Elsevier Inc. All rights reserved.
引用
收藏
页码:407 / 418
页数:12
相关论文
共 50 条
  • [1] Gut microbiome affects the response to immunotherapy in non-small cell lung cancer
    Ren, Shengnan
    Feng, Lingxin
    Liu, Haoran
    Mao, Yuke
    Yu, Zhuang
    THORACIC CANCER, 2024, 15 (14) : 1149 - 1163
  • [2] Effect of Gut Microbiome on Metastasis of Non-small Cell Lung Cancer
    Liu, C. -G.
    Sun, J. -Z.
    Zang, D.
    Chen, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S263 - S263
  • [3] Gut Microbiome and Metabolite Characteristics Associated With Different Clinical Stages in Non-Small Cell Lung Cancer Patients
    Liu, Fan
    Lu, Xingbing
    Tang, Mengli
    Chen, Yuzuo
    Zheng, Xi
    CANCER MANAGEMENT AND RESEARCH, 2025, 17
  • [4] Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review
    Nagasaka, Misako
    Sexton, Rachel
    Alhasan, Roba
    Rahman, Sarah
    Asfar, Azmi S.
    Sukari, Ammar
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 145
  • [5] Modulating the gut microbiome in non-small cell lung cancer: Challenges and opportunities
    Lee, Jii Bum
    Huang, Yiqing
    Oya, Yuko
    Nutzinger, Jorn
    LE Ang, Yvonne
    Sooi, Kenneth
    Cho, Byoung Chul
    Soo, Ross A.
    LUNG CANCER, 2024, 194
  • [6] The association between gut microbiome and response to checkpoint inhibitor therapy in non-small cell lung cancer
    Moon, J.
    Moon, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S709 - S710
  • [7] Concurrent chemoradiotherapy in non-small cell lung cancer
    O'Rourke, Noelle
    Roque i Figuls, Marta
    Farre Bernado, Nuria
    Macbeth, Fergus
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (06):
  • [8] Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer
    Anna Grenda
    Ewelina Iwan
    Izabela Chmielewska
    Paweł Krawczyk
    Aleksandra Giza
    Arkadiusz Bomba
    Małgorzata Frąk
    Anna Rolska
    Michał Szczyrek
    Robert Kieszko
    Tomasz Kucharczyk
    Bożena Jarosz
    Dariusz Wasyl
    Janusz Milanowski
    AMB Express, 12
  • [9] Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer
    Grenda, Anna
    Iwan, Ewelina
    Chmielewska, Izabela
    Krawczyk, Pawel
    Giza, Aleksandra
    Bomba, Arkadiusz
    Frak, Malgorzata
    Rolska, Anna
    Szczyrek, Michal
    Kieszko, Robert
    Kucharczyk, Tomasz
    Jarosz, Bozena
    Wasyl, Dariusz
    Milanowski, Janusz
    AMB EXPRESS, 2022, 12 (01)
  • [10] Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC)
    Sitthideatphaiboon, Piyada
    Somlaw, Nicha
    Zungsontiporn, Nicha
    Ouwongprayoon, Pongsakorn
    Sukswai, Narittee
    Korphaisarn, Krittiya
    Poungvarin, Naravat
    Aporntewan, Chatchawit
    Vinayanuwattikun, Chanida
    Hirankarn, Nattiya
    Chanida, Vinayanuwattikun
    SCIENTIFIC REPORTS, 2024, 14 (01):